Cargando…
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study
BACKGROUND: Home-based (unsupervised) buprenorphine initiation is considered safe and effective, yet many patients report barriers to successful treatment initiation. Prescription digital therapeutics (PDTs) are software-based disease treatments regulated by the US Food and Drug Administration (FDA)...
Autores principales: | Luderer, Hilary, Enman, Nicole, Gerwien, Robert, Braun, Stephen, McStocker, Samantha, Xiong, Xiaorui, Koebele, Carrington, Cannon, Christopher, Glass, Joseph, Maricich, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898828/ https://www.ncbi.nlm.nih.gov/pubmed/36662568 http://dx.doi.org/10.2196/43122 |
Ejemplares similares
-
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders
por: Xiong, Xiaorui, et al.
Publicado: (2022) -
Patient Engagement With a Game-Based Digital Therapeutic for the Treatment of Opioid Use Disorder: Protocol for a Randomized Controlled Open-Label, Decentralized Trial
por: Luderer, Hilary, et al.
Publicado: (2022) -
Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014) -
A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2012) -
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)